Is ICI 182,780 an antiprogestin in addition to being an antiestrogen? (Q40874389)

24 September 2017

title

Is ICI 182,780 an antiprogestin in addition to being an antiestrogen? (English)

1 reference

24 September 2017

author

Eleftherios P. Diamandis

5

1 reference

ORCID Public Data File 2021

24 September 2017

1 reference

author name string

R S Rosenberg Zand

1

1 reference

24 September 2017

L Grass

2

1 reference

24 September 2017

A Magklara

3

1 reference

24 September 2017

D J Jenkins

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Breast Cancer Research and Treatment

24 September 2017

published in

1 reference

24 September 2017

volume

60

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

1-8

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006334132303

24 September 2017

exact match

0 references

cites work

Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

New endocrine therapies for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

A new triphenylethylene compound, Fc-1157a. II. Antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

7 January 2021

Antagonism of estrogen action with a new benzothiophene derived antiestrogen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

7 January 2021

TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

7 January 2021

Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

7 January 2021

Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

7 January 2021

Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

7 January 2021

Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

7 January 2021

Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006334132303

7 January 2021

Identifiers

DOI

10.1023/A:1006334132303

1 reference

Dimensions Publication ID

24 September 2017

1025261668

0 references

1 reference